Citigroup’s ATAI Life Sciences ATAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.4K | Sell |
4,763
-128,782
| -96% | -$282K | ﹤0.01% | 4444 |
|
|
2025
Q1 | $182K | Buy |
133,545
+130,711
| +4,612% | +$178K | ﹤0.01% | 3494 |
|
|
2024
Q4 | $3.77K | Sell |
2,834
-145
| -5% | -$193 | ﹤0.01% | 4631 |
|
|
2024
Q3 | $3.46K | Sell |
2,979
-567
| -16% | -$658 | ﹤0.01% | 4563 |
|
|
2024
Q2 | $4.72K | Buy |
3,546
+2,704
| +321% | +$3.6K | ﹤0.01% | 4509 |
|
|
2024
Q1 | $1.66K | Sell |
842
-2,391
| -74% | -$4.71K | ﹤0.01% | 4613 |
|
|
2023
Q4 | $4.56K | Buy |
3,233
+945
| +41% | +$1.33K | ﹤0.01% | 4570 |
|
|
2023
Q3 | $2.95K | Sell |
2,288
-8,295
| -78% | -$10.7K | ﹤0.01% | 4115 |
|
|
2023
Q2 | $18.2K | Buy |
10,583
+5,569
| +111% | +$9.58K | ﹤0.01% | 4295 |
|
|
2023
Q1 | $9.08K | Sell |
5,014
-242
| -5% | -$438 | ﹤0.01% | 4106 |
|
|
2022
Q4 | $14K | Sell |
5,256
-32,666
| -86% | -$86.9K | ﹤0.01% | 4021 |
|
|
2022
Q3 | $126K | Sell |
37,922
-749
| -2% | -$2.49K | ﹤0.01% | 3288 |
|
|
2022
Q2 | $141K | Sell |
38,671
-1,704
| -4% | -$6.21K | ﹤0.01% | 3372 |
|
|
2022
Q1 | $206K | Sell |
40,375
-57,270
| -59% | -$292K | ﹤0.01% | 3385 |
|
|
2021
Q4 | $745K | Buy |
97,645
+39,766
| +69% | +$303K | ﹤0.01% | 2797 |
|
|
2021
Q3 | $856K | Buy |
+57,879
| New | +$856K | ﹤0.01% | 2508 |
|